Literature DB >> 6311901

Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).

P Gros, E Skamene, A Forget.   

Abstract

Multiplication of Mycobacterium bovis (BCG) in the reticuloendothelial tissues of the mouse is controlled by the Chromosome 1 locus (Bcg), which exists in two allelic forms, resistant (Bcgr) and susceptible (Bcgs). We have investigated the phenotypic expression of this locus at the cellular level in vivo. No significant differences were observed in the early clearance of BCG from the bloodstream and peritoneal cavity, nor in the uptake of the infectious inoculum in spleen and liver of the mice of Bcgr and Bcgs strains. Inflammatory response to an i.p. injection of live BCG, with respect to both the cell populations involved and the kinetics of their appearance, was comparable in Bcgr and Bcgs mice. A kinetic study of BCG infection in congenitally athymic mice that carried the "nude" mutation on Bcgr (AKR/J) or Bcgs (BALB/c) background showed that the functional absence of T lymphocytes did not influence the expression of the Bcg gene. The population expressing the Bcg gene seems to be a mature cell of the mononuclear phagocyte lineage: it was resistant to a 950-rad dose of x-irradiation; it was susceptible to a prolonged exposure to silica; and, as demonstrated in radiation chimeras, it originated from bone marrow-derived precursors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311901

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Functional expression of Nramp1 in vitro in the murine macrophage line RAW264.7.

Authors:  G Govoni; F Canonne-Hergaux; C G Pfeifer; S L Marcus; S D Mills; D J Hackam; S Grinstein; D Malo; B B Finlay; P Gros
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  The in vivo antibody response against exogenous antigens is not influenced by the mouse Bcg (Nramp1) gene.

Authors:  M Sírová; O Hovorka; I Ríha; B Ríhová; M Baudys; S W Kim; E Skamene
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene.

Authors:  Y Goto; E Buschman; E Skamene
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Nramp defines a family of membrane proteins.

Authors:  M Cellier; G Privé; A Belouchi; T Kwan; V Rodrigues; W Chia; P Gros
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Cloning and characterization of a second human NRAMP gene on chromosome 12q13.

Authors:  S Vidal; A M Belouchi; M Cellier; B Beatty; P Gros
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

6.  Induction and expression of protective T cells during Mycobacterium avium infections in mice.

Authors:  R Appelberg; J Pedrosa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

7.  Macrophage uptake and retention of radiolabeled glycopeptidolipid antigens associated with the superficial L1 layer of Mycobacterium intracellulare serovar 20.

Authors:  L C Hooper; M M Johnson; V R Khera; W W Barrow
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

8.  Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans.

Authors:  M Puliti; D Radzioch; R Mazzolla; R Barluzzi; F Bistoni; E Blasi
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages.

Authors:  A M Sarmento; R Appelberg
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis.

Authors:  Pere-Joan Cardona; Sergi Gordillo; Jorge Díaz; Gustavo Tapia; Isabel Amat; Angeles Pallarés; Cristina Vilaplana; Aurelio Ariza; Vicenç Ausina
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.